A Form 144 notice of proposed sale was filed on November 2, 2026, by the Koopmans Family Trust U/A DTD 03/28/2013, an officer-affiliated trust at Marvell Technology, Inc., disclosing plans to sell 10,000 shares of common stock on NASDAQ:MRVL.

Key Highlights

  • Proposed sale: 10,000 shares of Marvell Technology, Inc. common stock, with an aggregate market value of $1,869,674.00, are proposed for sale on or around November 2, 2026.
  • Selling party: The Koopmans Family Trust U/A DTD 03/28/2013, listed as having an officer relationship to the issuer, is the account for whose benefit the shares are to be sold.
  • Shares outstanding: According to the filing, 876,900,000 shares of Marvell Technology, Inc. common stock were outstanding at the time of notice.
  • Acquisition source: The 10,000 shares were acquired on April 15, 2026, through performance and restricted stock granted by the issuer, with payment described as "Not Applicable."
  • 10b5-1 plan: The filing indicates the sale is being made pursuant to a Rule 10b5-1 plan adopted on June 16, 2026.
  • Prior three-month sales: The trust sold 10,000 shares on October 1, 2026, for gross proceeds of $2,620,515.00; 10,000 shares on September 1, 2026, for $2,032,703.00; and 10,000 shares on August 3, 2026, for $1,805,004.00.

Koopmans Family Trust Proposes November 2026 Share Sale Under 10b5-1 Plan

According to the Form 144 filing submitted on November 2, 2026, the Koopmans Family Trust U/A DTD 03/28/2013 intends to sell 10,000 shares of Marvell Technology, Inc. (NASDAQ:MRVL) common stock. The trust is identified in the filing as having an officer relationship to the issuer. The broker named to execute the proposed transaction is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

The filing discloses that the shares proposed for sale were acquired on April 15, 2026, through performance and restricted stock issued by Marvell Technology, Inc. The remarks section of the filing states: "The securities to be sold were acquired upon the vesting of restricted stock and Performance Shares during the period of 4/15/2026 through 10/15/2026." The filing further indicates the sale is being conducted under a Rule 10b5-1 trading plan adopted on June 16, 2026.

The filing also reports three prior sales by the same trust over the preceding three months. The trust sold 10,000 shares on August 3, 2026, for gross proceeds of $1,805,004.00; 10,000 shares on September 1, 2026, for $2,032,703.00; and 10,000 shares on October 1, 2026, for $2,620,515.00. The proposed November sale carries an aggregate market value of $1,869,674.00, against a total of 876,900,000 shares reported as outstanding. The notice was signed "/s/ Chris Koopmans."

What Was Disclosed

The filing is a Form 144 notice from the Koopmans Family Trust U/A DTD 03/28/2013 disclosing a proposed sale of 10,000 Marvell Technology, Inc. common shares valued at $1,869,674.00, under a 10b5-1 plan dated June 16, 2026, with the approximate sale date of November 2, 2026.